Medicago Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Medicago Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014327
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medicago Inc (Medicago), a subsidiary of Mitsubishi Tanabe Pharma Corp is a biopharmaceutical company that develops and produces vaccines and antibodies. The company concentrates on the discovery and development of novel vaccines and therapeutic proteins for infectious diseases. Its pipeline products includes pandemic flu vaccine and seasonal flu vaccines. Medicago’s seasonal flu vaccine is used for contagious respiratory illness. The company also develops H1N1 pandemic candidate vaccines; and rabies, rotavirus and biosimilar vaccination. It uses its technologies including plant-based proficia technology, virus-like particles and the VLPExpress platform for the development of vaccines. The company conducts research activities in the areas of biodefence and biosimilar therapies. It operates in North Carolina, and production facility in Canada. Medicago is headquartered in Quebec, Canada.

Medicago Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Medicago Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Medicago Enters into Contract with Public Health Agency of Canada 10
Medicago Enters into Agreement with University of Cape Town 11
Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12
Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13
Medicago Enters Into Co-Development Agreement With Cellectis 14
Medicago Enters Into Research Collaboration With USAMRIID 15
Licensing Agreements 16
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 16
Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 17
Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 18
Equity Offering 19
Medicago Announces Private Placement Of Common Stock For US$3.4 Million 19
Medicago Completes Second Tranche Of Private Placement Of Shares For US$11 Million 20
Medicago Completes Private Placement Of Common Stock For US$24.5 Million 21
Medicago Completes Public Offering Of Units For US$17.72 Million 22
Acquisition 24
Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For US$ 172 Million In Going Private Transaction 24
Medicago Inc – Key Competitors 26
Medicago Inc – Key Employees 27
Medicago Inc – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Recent Developments 29
Clinical Trials 29
Sep 27, 2017: Mitsubishi Tanabe Pharma: Notice of the Start of Phase 3 Clinical Study of VLP Seasonal Influenza Vaccine 29
Sep 26, 2017: Medicago Announces Phase 3 Study of VLP Quadrivalent Influenza Vaccine 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
Medicago Inc, Pharmaceuticals & Healthcare, Key Facts 2
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Medicago Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Medicago Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Medicago Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Medicago Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Medicago Enters into Contract with Public Health Agency of Canada 10
Medicago Enters into Agreement with University of Cape Town 11
Medicago Enters Into Co-Development Agreement With A Global Pharma Company 12
Medicago Enters Into Co-Development Agreement With Mitsubishi Tanabe Pharma For Vaccines 13
Medicago Enters Into Co-Development Agreement With Cellectis 14
Medicago Enters Into Research Collaboration With USAMRIID 15
Immune Design And Medicago Enter Into Licensing Agreement To Develop Influenza Vaccines 16
Medicago Enters Into Licensing Agreement With Philip Morris Products For Influenza Vaccines 17
Philip Morris Products Enters Into Licensing Agreement With Medicago For Protein Development Technologies 18
Medicago Announces Private Placement Of Common Stock For US$3.4 Million 19
Medicago Completes Second Tranche Of Private Placement Of Shares For US$11 Million 20
Medicago Completes Private Placement Of Common Stock For US$24.5 Million 21
Medicago Completes Public Offering Of Units For US$17.72 Million 22
Medicago Completes Divestment Of 53.9% Stake To Mitsubishi Tanabe Pharma For US$ 172 Million In Going Private Transaction 24
Medicago Inc, Key Competitors 26
Medicago Inc, Key Employees 27
Medicago Inc, Other Locations 28
Medicago Inc, Subsidiaries 28

★海外企業調査レポート[Medicago Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Donaldson Co Inc (DCI):企業の財務・戦略的SWOT分析
    Donaldson Co Inc (DCI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Beam Suntory Inc.:企業の戦略・SWOT・財務分析
    Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report Summary Beam Suntory Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Capture Vascular Inc-医療機器分野:企業M&A・提携分析
    Summary Capture Vascular Inc (Capture Vascular) is a medical device development company that offers mechanical thrombectomy systems. The company offers MegaVac, a mechanical thrombectomy system that removes clots in arteries and provides vessel occlusion, embolic prevention and anchoring capabilitie …
  • Orly International, Inc.:企業の戦略・SWOT・財務分析
    Orly International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Orly International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Berkley Renewables Inc (BKS)-石油・ガス分野:企業M&A・提携分析
    Summary Berkley Renewables Inc (Berkley) is a venture firm that focuses on capturing opportunities in renewable energy, life sciences, and oil & gas sectors. The company essentially carries out power generation through the management and operation of solar photovoltaic plants . It also undertakes th …
  • Codexis Inc (CDXS)-製薬・医療分野:企業M&A・提携分析
    Summary Codexis Inc (Codexis) is a biotechnology company, which focuses on the development of biocatalysts for commercial scale production of fine chemicals and pharmaceuticals. The company’s product portfolio includes pharmaceutical enzymes and intermediates, active pharmaceutical ingredients (APIs …
  • Lebara Group:企業の戦略的SWOT分析
    Lebara Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Suntory Holdings Ltd:企業の戦略・SWOT・財務情報
    Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Suntory Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Wake Forest Innovations:製薬・医療:M&Aディール及び事業提携情報
    Summary Wake Forest Innovations (Wake Forest), a subsidiary of Wake Forest Baptist Medical Center, is a health care service provider. The center offers development and commercialization of discoveries; services; and products such as medicines and vaccines, from the Medical Center and Wake Forest Uni …
  • Hydrogenics Corporation (HYG):電力:M&Aディール及び事業提携情報
    Summary Hydrogenics Corporation (Hydrogenics) is a provider of power generation equipment. The company designs, develops, and manufactures hydrogen generation and fuel cell products. It produces products on water electrolysis and proton exchange membrane technologies. Hydrogenics also provides vario …
  • Sino Oil and Gas Holdings Ltd (702):企業の財務・戦略的SWOT分析
    Summary Sino Oil and Gas Holdings Ltd (Sino Oil and Gas), formerly Genesis Energy Holdings Ltd, is an oil and gas company that offers production and development of oil properties. The company offers services such as oil and gas exploration, production, distribution, development and supplying service …
  • SuperSonic Imagine SA (SSI):企業の財務・戦略的SWOT分析
    Summary SuperSonic Imagine SA (SuperSonic) is a medical device company that develops and supplies ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company offers ultrasound system, aixplorer that finds clinical applications in breast, abdomen, liver, vascular, …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Cold Spring Harbor Laboratory:製薬・医療:M&Aディール及び事業提携情報
    Summary Cold Spring Harbor Laboratory (CSHL) is a research and education institution that offers molecular biology and genetics services. The institution offers research services such as graduate research, research training, clinical research, quantitative biology research, postdoctoral research, di …
  • Biosearch Technologies Inc:医療機器:M&Aディール及び事業提携情報
    Summary Biosearch Technologies Inc (Biosearch), a subsidiary of LGC Ltd is a biotechnology company that designs and manufactures regents. The company develops, and manufactures custom oligonucleotide-based tools. Its products include valupanel reagents, fluorogenic probes and primers, stellaries RNA …
  • Teck Resources Ltd:企業のM&A・事業提携・投資動向
    Teck Resources Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Teck Resources Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Orbit Garant Drilling Inc.:企業の戦略・SWOT・財務情報
    Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report Summary Orbit Garant Drilling Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Idorsia Pharmaceutical Ltd (IDIA):製薬・医療:M&Aディール及び事業提携情報
    Summary Idorsia Pharmaceutical Ltd (Idorsia) is a manufacturer and developer of medicine that discovers, develops various therapies. The company provides pipeline portfolio such as investigational candidates targeted at the treatment of resistant hypertension, chronic insomnia, vasospasm, and system …
  • BP Australia Group Pty Ltd:企業の戦略的SWOT分析
    BP Australia Group Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Concord New Energy Group Ltd (182):電力:M&Aディール及び事業提携情報
    Summary Concord New Energy Group Limited (Concord), formerly China WindPower Group Limited, is a clean and renewable energy company that carries out the construction, operation and maintenance of, and investment in, wind and solar power electricity generating facilities in China. Concord’s core busi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆